Advances in the management of alopecia areata
- 29 December 2011
- journal article
- review article
- Published by Wiley in The Journal of Dermatology
- Vol. 39 (1), 11-17
- https://doi.org/10.1111/j.1346-8138.2011.01476.x
Abstract
Spontaneous remission occurs in up to 80% of patients with limited patchy alopecia areata (AA) within 1 year. Therefore, not all patients of AA simplex/multiplex need extensive treatments, and "wait and see" is one of the choices for some patients. However, once the hair loss show progressive course, it is really difficult to manage well and may be recalcitrant to any treatment in some cases. Hair loss symptom is not life-threatening but severely decreases quality of life. There have been two widely known guidelines for AA from the British Association of Dermatologists and the National Alopecia Areata Foundation (USA). These guidelines have been substantial and provide clues for dermatologists but needed to be updated. Recently, the Japanese Dermatological Association also published a guideline for the management of AA. This guideline suggests treatments followed by recommendations and evidence levels. Several new treatments are added such as corticosteroid pulse therapy and antihistamine drugs in addition to Japanese historical therapies. Although the highly recommended therapies are still contact immunotherapy and local injection of corticosteroid, it may result in improvement of AA by use of appropriate treatments decided by age, hair loss type, disease course and desire of the AA patient.Keywords
This publication has 65 references indexed in Scilit:
- Vertical vs. transverse sections of scalp biopsy specimens: a pilot study on the comparison of the diagnostic value of two techniques in alopeciaClinical and Experimental Dermatology, 2011
- Pigmented contact dermatitis due to therapeutic sensitizer as complication of contact immunotherapy in alopecia areataThe Journal of Dermatology, 2010
- Effect of thioredoxin reductase 1 on glucocorticoid receptor activity in human outer root sheath cellsBiochemical and Biophysical Research Communications, 2007
- Placebo-controlled oral pulse prednisolone therapy in alopecia areataJournal of the American Academy of Dermatology, 2005
- Alopecia areata investigational assessment guidelines*Journal of the American Academy of Dermatology, 1999
- Prognostic factors in the treatment of alopecia areata with diphenylcyclopropenoneJournal of the American Academy of Dermatology, 1991
- Double-blind, placebo-controlled evaluation of topical minoxidil in extensive alopecia areataJournal of the American Academy of Dermatology, 1987
- Action of topical minoxidil in the bald stump-tailed macaqueJournal of the American Academy of Dermatology, 1987
- Potential mechanisms of minoxidil-induced hair growth in alopecia areataJournal of the American Academy of Dermatology, 1987
- Squaric acid and esters: Analysis for contaminants and stability in solventsJournal of the American Academy of Dermatology, 1985